A milestone in the joimax® company history
joimax® receives FDA approval for the introduction of Intracs® em in the USA!
This achievement represents another important milestone in the company history of joimax®. With this landmark the way is paved for a wide adoption of endoscopy in spinal surgery.


The 71st annual meeting of the DGNC was the first virtual congress and joimax® participated with two “Meet the Expert” sessions and a virtual lunch symposium.


joimax® starts with a new workshop concept: Prior to the practical hands-on sessions on site in the company’s own training centre in Karlsruhe in small working groups (max. 3 participants), the theoretical workshop part is held as an online seminar with the participants.


joimax® is organising the first Global Online Symposium on April 24 and 25, 2020 entitled “Endoscopic Spine Surgery – Indications, Technology and Limitations”.
On April 24 joimax® founder and CEO Wolfgang Ries hosts a panel with the faculties Dr. Ralf Wagner and Christoph Hofstetter, MD, PhD. The following day faculty Junseok Bae, MD, took part in the panel discussion.
On both days a theoretical part on transforaminal and interlaminar indications as well as a practical hands-on part are being held.
With 430 participants the Online Symposium marks an important milestone.


joimax® launches its “Keep in Touch” program in the wake of the Covid-19 pandemic:
Faculty report about their cases, their way to endoscopic spine surgery or how they can deal with the current situation and increase their knowledge about endoscopy.